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Seven-valent pneumococcal conjugate vaccination commenced in 2001 for Australian indigenous in-
fants. Pneumococcal carriage surveillance detected substantial replacement with nonvaccine serotypes
and a cluster of serotype 1 carriage. Our aim was to review Streptococcus pneumoniae serotype 1 carriage
and invasive pneumococcal disease (IPD) data for this population and to analyze serotype 1 isolates.
Carriage data were collected between 1992 and 2004 in the Darwin region, one of the five regions in the
Northern Territory. Carriage data were also collected in 2003 and 2005 from four regions in the Northern
Territory. Twenty-six cases of serotype 1 IPD were reported from 1994 to 2007 in the Northern Territory.
Forty-four isolates were analyzed by BOX typing and 11 by multilocus sequence typing. In the Darwin
region, 26 children were reported carrying serotype 1 (ST227) in 2002 but not during later surveillance.
Scattered cases of serotype 1 carriage were noted in two other regions. Cocolonization of serotype 1 with
other pneumococcal serotypes was common (34% serotype 1-positive swabs). In conclusion, pneumococcal
carriage studies detected intermittent serotype 1 carriage and an ST227 cluster in children in indigenous
communities in the Northern Territory of Australia. There was no apparent increase in serotype 1 IPD
during this time. The rate of serotype 1 cocolonization with other pneumococcal serotypes suggests that
carriage of this serotype may be underestimated.
Seven-valent pneumococcal conjugate vaccine (PCV7) im-
munization for infants and catch-up immunization programs
commenced in 2001 for indigenous Australian children. The
incidence of invasive pneumococcal disease (IPD) in indige-
nous children less than 2 years of age in the Northern Territory
fell from approximately 600 cases/100,000 individuals to 264
cases/100,000 individuals after the introduction of PCV7 (9).
Serotype replacement in IPD is not confirmed in this popula-
tion as reported elsewhere (21). However, replacement with
nonvaccine serotypes is evident in carriage, and it is responsi-
ble for continued pneumococcal carriage rates in excess of
80% among young indigenous children (15). Following the
introduction of PCV7, our carriage surveys of children de-
tected a shift to a serotype hierarchy led by serotype 16F (14)
and a cluster of serotype 1 carriage.
Streptococcus pneumoniae serotype 1 is an important con-
tributor to IPD in children and adults in much of the world (6).
There can be substantial variations in the proportion of sero-
type 1 IPD in studies from the same population in different
years and from the same country at different sites. This is due
to the serotype’s propensity to cause outbreaks of disease (7).
Serotype 1 is associated with complicated pneumonia, pulmo-
nary empyema, peritonitis, and salpingitis (reviewed in refer-
ence 8) and was identified in a highly lethal pneumococcal
meningitis epidemic (27).
Serotype 1 is not commonly detected in studies of coloniza-
tion, presumably due to its short duration and low density of
carriage (7). However, serotype 1 carriage can be evident dur-
ing outbreaks of serotype 1 IPD. For example, a central Aus-
tralian community outbreak of predominantly adult serotype 1
bacteremic pneumonia was related to nasopharyngeal (NP)
colonization of 13 of 75 (17.3%) children with acute lower
respiratory tract infection (4). Furthermore, in a closed com-
munity in southern Israel, serotype 1 carriage in 26 of 650 (4%)
residents across all age groups was reported during an out-
break of serotype 1 disease in adults and children (2). We
found few reports of NP serotype 1 carriage in the absence of
a reported serotype 1 IPD outbreak, for example, among
young children at an outpatient clinic in Mozambique (0.5% of
192 pneumococcal isolates) (24), among outpatients present-
ing with acute otitis media or pneumonia in Switzerland (1.7%
of 1,540 isolates) (10), and among healthy children 7 years old
or older in Turkey (4.3% of 117 isolates) (1).
The aim of this study was to determine the molecular char-
acteristics of serotype 1 pneumococci detected in various car-
riage studies and those from cases of IPD in indigenous Aus-
tralians in remote communities in the Northern Territory of
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Australia. This included a 2002 cluster of serotype 1 carriage in
children.
MATERIALS AND METHODS
Ethics. The human research ethics committees of the Northern Territory
Department of Health and Community services and the Menzies School of
Health Research granted approval for the original studies and the analysis of
serotype 1 isolates.
Definition of studies and regions. The Northern Territory of Australia can be
divided into five administrative regions: the Darwin, Arnhem, Katherine, Barkly,
and Alice regions.
The primary focus of this report was serotype 1 carriage in four closely situated
communities in the Darwin region. Pneumococcal carriage in children and adults
in these communities was studied between 1992 and 2004 (Table 1, studies 1 to
4). Data from a nasal pneumococcal carriage surveillance study in children 0 to
6 years of age that was undertaken in 29 communities across the Arnhem,
Katherine, Darwin, and Alice regions of the Northern Territory and the Pitjant-
jatjara lands (included in the Alice region) in 2003 and 2005 were also included
(Table 1, study 5).
Pneumococcal immunization schedule for indigenous Australians. For indig-
enous infants, vaccination with PCV7 is recommended at 2, 4, and 6 months of
age, followed by the 23-valent pneumococcal polysaccharide vaccine (23PPV) at
18 to 24 months of age. 23PPV is also recommended for indigenous adults who
are 15 to 49 years of age and medically at risk and for those who are 50 years of
age and older (17).
Carriage data. NP or nasal swabs were collected from indigenous children
(less than 16 years of age) and adults enrolled in a series of longitudinal or
cross-sectional studies between 1992 and 2005 (Table 1). Pneumococcal carriage
data were collected from the databases of the specific projects listed in Table 1.
All projects were undertaken by trained research staff using standardized data
collection methods including WHO-recommended swab collection, storage, and
microbiological analysis techniques for nasal or NP swabs (19, 23). At least one
pneumococcal colony and any that were morphologically distinct were selected
from each swab for serotyping by the quellung method (Statens Serum Institut,
Denmark). Serotype 1 isolates were sent to a reference laboratory (Queensland
Health) for confirmation.
IPD data. IPD cases reported from Northern Territory hospital patients iden-
tifying the Northern Territory as their place of residence, and where the serotype
was known, were included. A case of IPD was defined as the isolation or
detection of S. pneumoniae from a blood, cerebrospinal fluid, or other sterile site
sample by nucleic acid testing. Enhanced surveillance and notification of IPD
began in 1994. Collection and analysis of IPD data and isolates have been
described previously (20, 26).
Molecular typing. All serotype 1 isolates were analyzed by BOX typing (25).
Selected isolates of each BOX type and region were further analyzed by mul-
tilocus sequence typing (MLST) (3) using primers found in the MLST database
(http://spneumoniae.mlst.net/misc/info.asp#experimental), with the exception of
the spi forward primer (spiF3, 5-CAGATTTTGCAAGCCTATGG), the recP
reverse primer (recPR2, 5-GCCGTGTACAGCATTAGTTC), and the ddl for-
ward primer (ddlF2, 5-GATGGCTCTGTTCAAGGATT).
RESULTS
Serotype 1 carriage in the four Darwin region communities.
The earliest study, conducted from 1992 to 1993 (study 1 [11]),
identified three infant pneumococcal serotype 1 carriers and,
furthermore, two carriers from among the siblings of study
participants (66 NP swabs were collected from siblings of 31
FIG. 1. Serotype 1 carriage in all studies. The number of serotype
1-positive swabs (the first serotype 1-positive swab for each individual)
and the total number of nasal or NP swabs collected each year in study
participants listed in Table 1 (excluding household contacts). Years
1992 to 2004 represent carriage in four Darwin region communities
(studies 1 to 4), whereas years 2003 and 2005 include cross-sectional
carriage surveillance data from 29 Northern Territory communities,
including Darwin region communities (study 5).
TABLE 1. Carriage study details
Study Description (reference) Study yr No.enrolled No. of swabs obtained
Median age at
enrollment
(mo)
Age range at
enrollment
(mo)
1a Longitudinal study of otitis media in
one community (11)
1992–1993 41 208 NP (2–4 weekly) 0.17 0.07–2.5
1b Pilot antibiotic trial in a subset of
study 1a (not published)
1993–1994 20 273 NP (2–4 weekly) 4.1 0.66–20.6
2 Randomized controlled trial of long-
term amoxicillin for treatment of
otitis media with effusion in three
communities (12)
1996–2001 125 1,032 NP (2–4 weekly,
then 1 every 6 mo)
2.8 0.2–19
3 Carriage study of infants receiving
PCV7 and 23PPV in three
communities (not published)
2001–2004 97 914 NP (2–4 weekly to
12 mo, then 1 at 18
and 24 mo)
1.13 0.23–7.96
4 Cross-sectional carriage surveys in
four indigenous communities
(13)a
2002b 192 206 85.7 24–188
2002c 306 307 414 195–945
2004b 159 166 89.6 25–176
2004c 232 234 431 197–962
5 Cross-sectional carriage surveillance
in children 0 to 6 yr old in 29
(2003) and 17 (2005) communities
(15)
2003 902 902 21.3 0.76–75
2005 818 818 33.7 0.36–72
a Some participants were swabbed twice; serotype 1 carriage was assessed on the first swab.
b Children less than 16 years of age.
c Adults 16 years and over.
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infants) (Table 1; Fig. 1). Longitudinal studies of infants and
some household contacts conducted from 1996 to 2001 (study
2 [12]) detected serotype 1 carriage in one parent but not in
children.
Subsequently, a 2002 cross-sectional pneumococcal carriage
survey (study 4 [13]) of 193 children (2 to 15 years of age) and
305 adults detected a cluster of serotype 1 carriage among
non-PCV7-vaccinated children 2 to 11 years of age in three of
the four participating communities. Serotype 1 was the second
most common serotype (after serotype 16F) carried by 13%
(21/158) of children in this age group. Another carriage study
of infants less than 2 years of age in the same communities
(study 3 [unpublished]) detected two further serotype 1 carri-
ers in 2002 and in early 2003. In 2004, a carriage surveillance
follow-up with study 4 participants failed to detect serotype
1 carriage. Since IPD surveillance began in 1994, there have
been no reported cases of serotype 1 IPD in these commu-
nities.
Serotype 1 carriage across the Northern Territory. Cross-
sectional surveillance of pneumococcal nasal carriage in 903
children living in 29 communities in 2003 (study 5 [15, 16])
detected serotype 1 carriage in three Arnhem region commu-
nities (seven isolates from 461 swabs in this region) (Fig. 1).
Further surveillance of 818 children in 17 communities in 2005
detected serotype 1 in two Katherine region communities
(three isolates from 154 swabs in this region). Serotype 1 pneu-
mococci were also detected in ear discharge samples from
children with serotype 1-negative nasal swabs: 1 child in 2003
and 1 child in 2005.
All IPD and serotype 1 IPD cases in the Northern Territory.
Twenty-six cases of serotype 1 IPD were recorded in the
Northern Territory between 1994 and 2007 (Fig. 2). These
cases were not from communities that had concomitant car-
riage studies. The median age of patients with serotype 1 IPD
was 26.5 years, and 86% of cases were indigenous Australians.
The serotype 1 IPD cases were associated with 20 cases of
(blood culture-positive) pneumonia, 3 cases of meningitis, and
1 case each of bacteremia, peritonitis, and septic arthritis.
There was a single death of an adult patient with bacteremia.
Duration and density of serotype 1 carriage. In longitudinal
studies with 2 to 4 weekly samplings, serotype 1 strains were
generally detected at single examinations. Only one child was
found to carry a serotype 1 pneumococcus strain at two con-
secutive examinations. This was followed by detection of sero-
type 1 in bilateral ear discharge samples 1 month later. Sero-
type 1 isolates were detected at low and very high densities, as
determined by a semiquantitative culture measure (22). Simul-
taneous colonization with other pneumococcal serotypes was
detected in 34% of serotype 1-positive nasal swabs, compared
with 14% of swabs with multiple colonization detected for all
serotypes, based on colony morphology (5). Cocolonization
with nonserotypeable pneumococci was evident in another 5%
of serotype 1-positive swabs.
Molecular typing. The serotype 1 isolates from NP and ear
discharge swabs collected in study 1 (1992 to 1993) were des-
ignated BOX type H (Table 2). MLST results from represen-
tative isolates corresponded to ST304 from the MLST data-
base. Serotype 1 carriage isolates from study 4 (2002) were
BOX type I, which corresponded to ST227 from the MLST
database. Serotype 1 isolates detected in other Northern Ter-
ritory communities in 2003 and 2005 were also BOX type I,
which corresponded to ST227.
Serotype 1 isolates from cases of IPD were available from
four regions in 2003 to 2004. The Darwin and Arnhem region
isolates were BOX type I (ST227), whereas the Katherine
region BOX type I isolate was ST3079. A BOX type J (ST3079)
was found in the Darwin region, and BOX type H (ST304) was
found in the Barkly region.
DISCUSSION
Pneumococcal carriage studies in adults and children de-
tected intermittent episodes of serotype 1 carriage and an
age-specific cluster in indigenous communities in the Northern
Territory of Australia. In the Darwin region, serotype 1 ST304
carriage was detected in five children in 1992 to 1993, and a
decade later, we identified a cluster of serotype 1 ST227 car-
riage. During the following 3 years, carriage of serotype 1
ST227 was detected in children in other communities in the
Darwin, Arnhem, and Katherine regions of the Northern Ter-
ritory. There was no apparent increase in serotype 1 IPD cases
during this time. Cases of serotype 1 ST227 IPD were not from
communities with concomitant carriage studies.
The apparent restriction of serotype 1 carriage to children
under 11 years of age during the carriage cluster may be re-
lated to the serotype 1 carriage detected 10 years earlier in
these communities. We can speculate that serotype 1 carriage
results in a protective immune response and that high-fre-
FIG. 2. Cases of all-serotype IPD and serotype 1 IPD in the North-
ern Territory. The total number of cases of IPD where serotype was
known and the number of cases of serotype 1 IPD cases in the North-
ern Territory between 1994 and 2007 are shown.
TABLE 2. Molecular types of serotype 1 pneumococci from
carriage and IPD studies
Study yr Studyno. Region Specimen
BOX type
(no.
tested)
MLST
(no. tested)
1992, 1993 1 Darwin NP H (5) 304 (1)
1992, 1993 1 Darwin Ear discharge H (1) 304 (1)
2002, 2003 3, 4 Darwin NP I (26) 227 (2)
2003 5 Arnhem NP I (3) 227 (1)
2005 5 Katherine NP I (4) 227 (1)
2003 IPD Arnhem Blood I (1) 227 (1)
2003 IPD Katherine Blood I (1) 3079 (1)
2004 IPD Darwin Blood I (1) 227 (1)
2004 IPD Darwin Blood J (1) 3079 (1)
2004 IPD Barkly Blood H (1) 304 (1)
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quency carriage will occur when a large proportion of the
population is susceptible. The apparent age specificity may also
relate to the overall reduction in pneumococcal carriage with
age: 72 to 89% in children less than 9 years of age, 45% at age
10, and 30% at age 15.
A study in a Portuguese day-care center demonstrated an
increase in the prevalence of serotype 1 carriage between 2001
(0%) and 2006 (3.1%). The authors suggested an association
between carriage and the introduction of PCV7 (18). It is
unclear from our study whether the observed cluster was a
replacement phenomenon related to the 2001 commencement
of infant immunization and catch-up PCV7 immunization pro-
grams. Furthermore, our data cannot ascertain whether the
absence of serotype 1 carriage among adults during the
carriage cluster in children is related to expanded 23PPV im-
munization recommendations (17).
In conclusion, we have detected serotype 1 strains circulat-
ing in carriage in indigenous children living in remote commu-
nities in the Northern Territory of Australia. The sequence
types of these strains are the same as internationally dissemi-
nated IPD strains, including those found in the Northern Ter-
ritory. It is generally believed that serotype 1 carriage is rarely
detected because it is short-lived. Our longitudinal data sup-
port this belief, and we suggest that carriage rates are further
underestimated because carriage may be “hidden” during co-
colonization with other serotypes. We can further speculate
from our data that serotype 1 carriage is more likely to be
detected among young children who have higher pneumococ-
cal acquisition rates and who are less likely than adults to have
had previous exposure to serotype 1.
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